Collectively, IRF4 can signal to regulate diverse transcriptional programs through complexes containing ET or AP1 TF motifs in different cell types depending on the corresponding cellular context, particularly T cell exhaustion in the TME, thus suggesting new directions for improving anti-tumor immunity by modulating IRF4-dependent transcription. The gene discussed is JUNB; the disease is neoplasm.